Opinion|Videos|May 7, 2024

Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

Turning the focus to non-statin therapies, the panel outlines logistical barriers and discusses the characteristics that guide treatment selection in patients with ASCVD.


Latest CME